SCHEMBL7961264

SCHEMBL7961264

Cc1c(C)c(C)c2[nH]c(COc3ccc(Cl)cc3)nc2c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 4/20 0.51
TDP1 Q9NUW8 2/20 0.51
POLB P06746 1/20 0.51
ALOX15 P16050 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TP53 P04637 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
PABPC1 P11940 1/20 0.40
MAPK1 P28482 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
PTGS2 P35354 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690658 0.78 RAB9A (0.56) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL7690656 0.78 RAB9A (0.56) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL7689804 0.75 RAB9A (0.63) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL7689808 0.75 RAB9A (0.63) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL8555194 0.71 SMN1; SMN2 (0.47) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL8553989 0.71 RAB9A (0.47) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL7692487 0.70 RAB9A (0.64) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL8554128 0.70 RAB9A (0.46) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL8555784 0.70 RAB9A (0.46) RAB9ASMN1; SMN2NPC1TDP1POLB
SCHEMBL8557031 0.70 RAB9A (0.46) RAB9ASMN1; SMN2NPC1TDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6255494-B1 SUBSTITUTED BENZIMIDAZOLES USEFUL IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH EXCESS OF NEUROPEPTIDE Y (AROUND ARTERIES IN HEART, RESPIRATORY TRACT, GASTROINTESTINAL TRACT AND GENITOURINARY TRACT); ETIOLOGY OF PSYCHIATRIC DISORDERS ELI LILLY AND COMPANY 2001-07-03 US disclosed
EP-0871442-A1 BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1998-10-21 EP disclosed
WO-1997025041-A1 BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-07-17 WO disclosed